Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Coherus BioSciences, Inc. (CHRS) - free report >>
Fulgent Genetics, Inc. (FLGT) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Coherus BioSciences, Inc. (CHRS) - free report >>
Fulgent Genetics, Inc. (FLGT) - free report >>
Image: Bigstock
New Strong Sell Stocks for August 17th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Accolade, Inc. (ACCD - Free Report) provides personalized, technology-enabled solutions which help people better understand, navigate and utilize the healthcare system. The Zacks Consensus Estimate for its current year earnings has been revised 10.9% downward over the last 30 days.
Coherus BioSciences, Inc. (CHRS - Free Report) is a biologics platform company developing biosimilar therapeutics. The Zacks Consensus Estimate for its current year earnings has been revised 20.5% downward over the last 30 days.
Elevate Credit, Inc. offers online credit solutions to non-prime consumers. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
Fulgent Genetics, Inc. (FLGT - Free Report) is a technology company that provides genetic testing services to physicians with clinically actionable diagnostic information. The Zacks Consensus Estimate for its current year earnings has been revised 2.3% downward over the last 30 days.
Goosehead Insurance, Inc (GSHD - Free Report) operates as an insurance agency. The Zacks Consensus Estimate for its current year earnings has been revised 15.5% downward over the last 30 days.
View the entire Zacks Rank #5 List.